Learning Objectives
- Understand the global burden of heart failure.
- Discuss the tested pharmacological treatment options for heart failure.
- Discuss ARNIs––the new class of heart failure therapy––and in particular LCZ696
Faculty
John McMurray
MD, FRCP, FACC, FESC, FRSE
Professor, Medical Cardiology, Institute of Cardiovascular and Medical Sciences, University of Glasgow
Scott D Solomon
MD
Senior Physician, Brigham and Women’s Hospital
Professor of Medicine, Harvard Medical School
Jonathan G Howlett
MD, FRCPC, FACC, FSCAI
Professor of Medicine and Director of Heart Failure Program, University of Calgary Foothills Medical Centre,
Chair of the Canadian Cardiovascular Society Heart Failure Guidelines Primary Panel
Anique Ducharme
MD, MSc, FRCPC
Associate Professor of Medicine, Université de Montréal
Founder and Director, Heart Failure Clinic, Montreal Heart Institute
Peter P Liu
MD, FRCPC
Professor of Medicine, University of Ottawa, University of Toronto
President, International Society of Heart Failure and the World Heart Federation
Jean L Rouleau
MD, FRCPC, FACC
Professor, Department of Medicine, Université de Montréal
Scientific Director, Institute of Circulatory and Respiratory Health
Subodh Verma
MD, PhD, FRCSC, FAHA
Division of Cardiac Surgery, St. Michael’s Hospital
Professor Surgery and Pharmacology & Toxicology, University of Toronto
Video Information
- Credit:No Credit Available
- Post Date:February 26, 2016
- Expiry Date:N/A
